Renal Cancers Completed Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00072046Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)Treatment